EyePoint Pharmaceuticals, Inc. (EYPT)

NASDAQ: EYPT · Real-Time Price · USD

5.05

-0.37 (-6.83%)

At close: Apr 1, 2025, 4:00 PM

5.18

+0.13 (2.57%)

After-hours: Apr 1, 2025, 5:00 PM EDT

EyePoint Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019 - 2015
Revenue	43.27	46.02	41.4	36.94	34.44	Upgrade
Revenue Growth (YoY)	-5.96%	11.14%	12.09%	7.27%	69.10%	Upgrade
Cost of Revenue	22.18	9.28	57.97	36.07	23.25	Upgrade
Gross Profit	21.09	36.74	-16.56	0.87	11.19	Upgrade
Selling, General & Admin	55.23	52.96	60.32	53.68	46.02	Upgrade
Research & Development	111.72	58.85	-	-	-	Upgrade
Operating Expenses	166.94	111.8	62.37	56.14	48.48	Upgrade
Operating Income	-145.85	-75.07	-78.94	-55.28	-37.29	Upgrade
Interest Expense	-0.01	-1.25	-3.19	-5.5	-7.26	Upgrade
Interest & Investment Income	15.09	6.95	2.13	0.29	0.06	Upgrade
EBT Excluding Unusual Items	-130.78	-69.37	-80	-60.48	-44.49	Upgrade
Asset Writedown	-	-	-20.7	-	-	Upgrade
Other Unusual Items	-	-1.35	-1.56	2.07	-0.91	Upgrade
Pretax Income	-130.78	-70.71	-102.25	-58.42	-45.39	Upgrade
Income Tax Expense	0.09	0.08	-	-	-	Upgrade
Net Income	-130.87	-70.8	-102.25	-58.42	-45.39	Upgrade
Net Income to Common	-130.87	-70.8	-102.25	-58.42	-45.39	Upgrade
Shares Outstanding (Basic)	56	39	37	29	13	Upgrade
Shares Outstanding (Diluted)	56	39	37	29	13	Upgrade
Shares Change (YoY)	44.71%	4.25%	29.76%	124.04%	23.06%	Upgrade
EPS (Basic)	-2.32	-1.82	-2.74	-2.03	-3.54	Upgrade
EPS (Diluted)	-2.32	-1.82	-2.74	-2.03	-3.54	Upgrade
Free Cash Flow	-130.28	-1.61	-67.16	-50.25	-14.8	Upgrade
Free Cash Flow Per Share	-2.31	-0.04	-1.80	-1.75	-1.15	Upgrade
Gross Margin	48.73%	79.83%	-40.01%	2.35%	32.49%	Upgrade
Operating Margin	-337.06%	-163.13%	-190.65%	-149.64%	-108.29%	Upgrade
Profit Margin	-302.43%	-153.84%	-246.97%	-158.15%	-131.82%	Upgrade
Free Cash Flow Margin	-301.06%	-3.49%	-162.19%	-136.04%	-42.97%	Upgrade
EBITDA	-144.31	-74.6	-76.49	-52.51	-34.64	Upgrade
EBITDA Margin	-	-162.12%	-184.75%	-142.14%	-100.59%	Upgrade
D&A For EBITDA	1.54	0.46	2.45	2.77	2.65	Upgrade
EBIT	-145.85	-75.07	-78.94	-55.28	-37.29	Upgrade
EBIT Margin	-	-163.13%	-190.65%	-149.64%	-108.29%	Upgrade
Revenue as Reported	43.27	46.02	41.4	36.94	34.44	Upgrade

Updated Mar 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q